What happens when you stop using Wegovy?

Health & LifestyleNews
137

Listen to article (english)

Translate to Spanish or other 102 languages!

Wegovy (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist used for weight loss and weight management and to reduce the risk of major cardiovascular events. Image for illustration purposes
Wegovy (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist used for weight loss and weight management and to reduce the risk of major cardiovascular events. Image for illustration purposes

Mega Doctor News

- Advertisement -

Medical News Today

Wegovy (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist used for weight loss and weight management and to reduce the risk of major cardiovascular events. The Wegovy injection is also approved to treat noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver fibrosis in adults.

Wegovy is available as a weekly injection and a once-daily tablet.

- Advertisement -

Stopping Wegovy, especially suddenly, can affect a person’s body and condition management goals. A person should always talk with their prescribing doctor before stopping Wegovy or any prescription medication.

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/drugs-what-happens-when-you-stop-taking-wegovy?utm_term=feedcontent&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2026-02-24&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

Information source: https://www.medicalnewstoday.com

- Advertisement -

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Heart Disease in Women: The Myths Putting Lives at Risk
Next article
How UTIs Trigger Delirium and Speed Cognitive Decline in Older Adults

More Articles

DHR Health to Host Free Adult Epilepsy Seminar, Aug. 15th

 DHR Health, together with the Epilepsy Foundation Central and South Texas, will host a free community health education seminar that will focus on epilepsy and supporting adults living with the condition

Lab-Grown Mini Organs Show Promise in Predicting Breast Cancer Treatment Outcomes

Researchers at UC San Francisco have developed a new method to predict how different types of breast cancer will respond to treatment, using patient data from the I-SPY2 breast cancer trial and rapid testing on lab-grown mini tumors. 

STHS Hosting Community Blood Drive Amid National Blood Shortage, August 21st 

The United States is facing a severe blood shortage, prompting the American Red Cross to issue only the second national blood crisis declaration in its history.

DHR Health Recertified for Advanced Hip & Knee Replacements

DHR Health has once again earned The Joint Commission's Advanced Certification in Total Hip and Total Knee Replacement, reaffirming its commitment to providing high-quality, patient-centered orthopedic care to the Rio Grande Valley.
- Advertisement -